Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition.
Catalano A, Adlesic M, Kaltenbacher T, Klar RFU, Albers J, Seidel P, Brandt LP, Hejhal T, Busenhart P, Röhner N, Zodel K, Fritsch K, Wild PJ, Duyster J, Fritsch R, Brummer T, Frew IJ.
Catalano A, et al. Among authors: hejhal t.
Cancers (Basel). 2021 Apr 13;13(8):1852. doi: 10.3390/cancers13081852.
Cancers (Basel). 2021.
PMID: 33924486
Free PMC article.